Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of BP1.4979 in Adult Patients With Essential Tremor

NCT07074002 is registered in ClinicalTrials.gov with Bioprojet as lead sponsor.

NCT NCT07074002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07074002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of BP1.4979 in Adult Patients With Essential Tremor
Lead sponsor
Bioprojet
Phase
Phase 2
Overall status
Recruiting
Start date
September 17, 2025
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

essential tremor